Integration of CD4 T cells and molecular subtype predicts benefit from PD-L1 blockade in muscle-invasive bladder cancer.
Muscle-invasive bladder cancer (MIBC) is a disease characterized by molecular and clinical heterogeneity, posing challenges in selecting the most appropriate treatment in clinical settings. Considering the significant role of...
Read More